دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Elsewhere in the AGA Journals
doi : 10.1016/S1542-3565(24)00262-3
Volume 22, Issue 5, May 2024, Pages A11-A13
Adenomyomatous Hyperplasia of the Ampulla of Vater
Kento Yasumura, Ryuki Minami, Taro Ueo
doi : 10.1016/j.cgh.2023.11.016
Volume 22, Issue 5, May 2024, Pages A25-A26
Unusual Villiform Re-epithelialization in Barrett's Esophagus Following Endoscopic Treatment
Kareem Khalaf, Katarzyna M. Pawlak, Gary R. May
doi : 10.1016/j.cgh.2023.11.021
Volume 22, Issue 5, May 2024, Pages A27-A28
Mesalazine-Induced Obstructive Intrahepatic and Extrahepatic Bile Duct Inflammation Mimicking Cholangiocarcinoma
Nicolai D. Vad 1, Yousef J.W. Nielsen 2, Casper Steenholdt 1
doi : 10.1016/j.cgh.2023.11.028
Volume 22, Issue 5, May 2024, Pages A31-A32
Blue Notes
Charles J. Kahi MD, MS, AGAF
doi : 10.1016/j.cgh.2024.02.020
Volume 22, Issue 5, May 2024, Pages 911-912
Meeting Summary: AGA Roundtable on Clinical Trial Design in Inflammatory Bowel Disease
Siddharth Singh 1 ∗, Jessica Allegretti 2 ∗, Yanina Nersesova 3, Sonya Serra 3, Alison Kim 3
doi : 10.1016/j.cgh.2023.12.005
Volume 22, Issue 5, May 2024, Pages 913-918
Emotional Intelligence: An Impactful Yet Often Overlooked Skill That Can Enhance Physician Well-being and Professional Satisfaction
David J. Hass 1 2, Marc A. Brackett 2 3
doi : 10.1016/j.cgh.2024.02.019
Volume 22, Issue 5, May 2024, Pages 919-922
Common Instances of Low-value Care in Inflammatory Bowel Diseases
Siddharth Singh 1 2, Fernando S. Velayos 3, David T. Rubin 4
doi : 10.1016/j.cgh.2023.09.043
Volume 22, Issue 5, May 2024, Pages 923-932
AGA Clinical Practice Update on High-Quality Upper Endoscopy: Expert Review
Satish Nagula 1, Sravanthi Parasa 2, Loren Laine 3 4, Shailja C. Shah 5 6
doi : 10.1016/j.cgh.2023.10.034
Volume 22, Issue 5, May 2024, Pages 933-943
White Paper: American Gastroenterological Association Position Statement: The Future of IBD Care in the United States–Removing Barriers and Embracing Opportunities
M. Anthony Sofia 1 ∗, Joseph D. Feuerstein 2 ∗, Leslie Narramore 3, Karen A. Chachu 4, Sarah Streett 5
doi : 10.1016/j.cgh.2024.01.050
Volume 22, Issue 5, May 2024, Pages 944-955
Crohn’s Disease: An Equal Opportunity Burden
Florence-Damilola Odufalu, Edward V. Loftus Jr., Sophie Balzora
doi : 10.1016/j.cgh.2023.08.029
Volume 22, Issue 5, May 2024, Pages 956-957
Assessing Risk of Index Serrated Polyps
Joseph C. Anderson, Lynn F. Butterly
doi : 10.1016/j.cgh.2023.10.020
Volume 22, Issue 5, May 2024, Pages 958-960
Risk of Major Adverse Cardiovascular Events in Immune-Mediated Inflammatory Disorders on Biologics and Small Molecules: Network Meta-Analysis
Shivani Shah Mattay 1 ∗, Mohammad Zamani 1 2 ∗, Dany Saturno 1, Edward V. Loftus Jr. 3, Matthew A. Ciorba 1, Andres Yarur 4, Siddharth Singh 5, Parakkal Deepak 1
doi : 10.1016/j.cgh.2023.09.033
Volume 22, Issue 5, May 2024, Pages 961-970.e12
Lack of Effectiveness of Computer Aided Detection for Colorectal Neoplasia: A Systematic Review and Meta-Analysis of Nonrandomized Studies
Harsh K. Patel 1 ∗, Yuichi Mori 2 3 ∗, Cesare Hassan 4 5, Tommy Rizkala 5, Dhruvil K. Radadiya 1, Piyush Nathani 1, Sachin Srinivasan 1, Masashi Misawa 3, Roberta Maselli 4 5, Giulio Antonelli 6 7, Marco Spadaccini 4 5, Antonio Facciorusso 8, Kareem Khalaf 9, Davide Lanza 10, Giacomo Bonanno 11, Douglas K. Rex 12, Alessandro Repici 4 5 §, Prateek Sharma 12 13 §
doi : 10.1016/j.cgh.2023.11.029
Volume 22, Issue 5, May 2024, Pages 971-980.e15
Reduction of Upper Gastrointestinal Bleeding Risk With Proton Pump Inhibitor Therapy in Asian Patients With Atrial Fibrillation Receiving Direct Oral Anticoagulant: A Nationwide Population-based Cohort Study
So-Ryoung Lee 1 2 ∗, Hyo-Jeong Ahn 1 ∗, Eue-Keun Choi 1 2, Sang-Hyun Park 3, Kyung-Do Han 4, Seil Oh 1 2, Gregory Y.H. Lip 2 5 6
doi : 10.1016/j.cgh.2023.12.022
Volume 22, Issue 5, May 2024, Pages 981-993.e11
Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment
Kasper A. Overbeek 1, Jakob L. Poulsen 2, Marco Lanzillotta 3, Olof Vinge-Holmquist 4 5, Peter Macinga 6, A. Fatih Demirci 7, Daniko P. Sindhunata 8, Johanna Backhus 9, Hana Algül 10, Jorie Buijs 1, Philippe Levy 11, Mariia Kiriukova 12, Elisabetta Goni 13, Marcus Hollenbach 14, Rainer C. Miksch 15, Lumir Kunovsky 16 17 18, Miroslav Vujasinovic 19, Sara Nikolic 19, Luke Dickerson 20, Michael Hirth 21…N. Gubergrits
doi : 10.1016/j.cgh.2023.12.010
Volume 22, Issue 5, May 2024, Pages 994-1004.e10
Prospective Comparison of Attenuation Imaging and Controlled Attenuation Parameter for Liver Steatosis Diagnosis in Patients With Nonalcoholic Fatty Liver Disease and Type 2 Diabetes
Marco Dioguardi Burgio 1 2, Laurent Castera 3, Mehdi Oufighou 1, Pierre-Emmanuel Rautou 2 4, Valérie Paradis 2 5, Pierre Bedossa 5, Riccardo Sartoris 1, Maxime Ronot 1 2, Sylvain Bodard 6 7, Philippe Garteiser 2, Bernard Van Beers 1 2, Dominique Valla 2 4, Valérie Vilgrain 1 2 ∗, Jean Michel Correas 6 7 8 ∗, QUID – NASH Investigators
doi : 10.1016/j.cgh.2023.11.034
Volume 22, Issue 5, May 2024, Pages 1005-1013.e27
Older Patients With Acute on Chronic Liver Failure Have a Higher Waitlist Mortality, but Acceptable Post Liver Transplantation Survival When Compared to Younger Patients
Joseph J. Alukal 1 2, Feng Li 1, Paul J. Thuluvath 1 3
doi : 10.1016/j.cgh.2023.11.035
Volume 22, Issue 5, May 2024, Pages 1014-1023.e6
Age, BMI, and Type 2 Diabetes Modify the Relationship Between PNPLA3 and Advanced Fibrosis in Children and Adults With NAFLD
Chaowapong Jarasvaraparn 1 ∗, Eduardo Vilar-Gomez 2 ∗, Katherine P. Yates 3, Laura A. Wilson 3, Brent Neuschwander-Tetri 4, Rohit Loomba 5, Oscar Cummings 6, Miriam Vos 7, Stavra Xanthakos 8, Jeffrey Schwimmer 9 10, Jean P. Molleston 1, Arun Sanyal 11, James Tonascia 12, Naga Chalasani 2
doi : 10.1016/j.cgh.2023.12.009
Volume 22, Issue 5, May 2024, Pages 1024-1036.e2
Screening for Fibrosis Promotes Lifestyle Changes: AÂ Prospective Cohort Study in 4796 Individuals
Maria Kjaergaard 1 2, Katrine Prier Lindvig 1 2, Katrine Holtz Thorhauge 1 2, Stine Johansen 1 2, Johanne Kragh Hansen 1 2, Peter Andersen 1, Camilla Dalby Hansen 1 2, Helle Lindholm Schnefeld 1, Katrine Tholstrup Bech 1, Nikolaj Torp 1 2, Mads Israelsen 1 2, Sönke Detlefsen 2 3, Isabel Graupera 4 5, Pere Gines 4 5, Aleksander Krag 1 2, Maja Thiele 1 2
doi : 10.1016/j.cgh.2023.12.018
Volume 22, Issue 5, May 2024, Pages 1037-1047.e9
Misclassified Alcohol-related Liver Disease is Common in Presumed Metabolic Dysfunction-associated Steatotic Liver Disease and Highly Increases Risk for Future Cirrhosis
Patrik Nasr 1 2, Axel Wester 2, Mattias Ekstedt 1, Rickard Strandberg 2, Stergios Kechagias 1, Ying Shang 2, Linnea Widman 2, Hannes Hagström 2 3
doi : 10.1016/j.cgh.2024.01.006
Volume 22, Issue 5, May 2024, Pages 1048-1057.e2
Development of an MRI-Based Prediction Model for Anti-TNF Treatment Failure in Perianal Crohn’s Disease: A Multicenter Study
Jeffrey D. McCurdy 1 2, Javeria Munir 3, Simon Parlow 1, Jacqueline Reid 4, Russell Yanofsky 5, Talal Alenezi 5, Joseph Meserve 6, Brenda Becker 7, Zubin Lahijanian 8, Anas Hussam Eddin 9, Ranjeeta Mallick 2, Tim Ramsay 2, Greg Rosenfeld 4, Ali Bessissow 8, Talat Bessissow 5, Vipul Jairath 9, Siddharth Singh 6, David H. Bruining 7, Blair Macdonald 2 3, the Canadian IBD Research Consortium
doi : 10.1016/j.cgh.2023.12.006
Volume 22, Issue 5, May 2024, Pages 1058-1066.e2
Cardiovascular Safety of Ozanimod in Patients With Ulcerative Colitis: True North and Open-Label Extension Analyses
Alessandro Armuzzi 1 2, Raymond K. Cross 3, Gary R. Lichtenstein 4, Jason Hou 5, Parakkal Deepak 6, Miguel Regueiro 7, Douglas C. Wolf 8, Lucy Akukwe 9, Harris A. Ahmad 9, Anjali Jain 9, Marc Kozinn 9, Hsiuanlin Wu 9, AnnKatrin Petersen 9, Lorna Charles 9, Millie Long 10
doi : 10.1016/j.cgh.2023.11.018
Volume 22, Issue 5, May 2024, Pages 1067-1076.e3
ENTERPRET: A Randomized Controlled Trial of Vedolizumab Dose Optimization in Patients With Ulcerative Colitis Who Have Early Nonresponse
Vipul Jairath 1 ∗, Andres Yarur 2 ∗, Mark T. Osterman 3, Alexandra James 4, Diane Balma 4, Shailly Mehrotra 4, Lili Yang 4, Vijay Yajnik 4, Rana M. Qasim Khan 4
doi : 10.1016/j.cgh.2023.10.029
Volume 22, Issue 5, May 2024, Pages 1077-1086.e13
Burden of Crohn’s Disease in the United States Medicaid Population, 2010–2019
Susan Hutfless 1, Ryan A. Jasper 2, Po-Hung Chen 3, Shelly Joseph 4, Steve Miller 5, Steven R. Brant 3 6
doi : 10.1016/j.cgh.2023.05.002
Volume 22, Issue 5, May 2024, Pages 1087-1097.e6
Prolonged Gastrointestinal Manifestations After Recovery From COVID-19
B. Joseph Elmunzer 1 ∗, Olafur S. Palsson 2 ∗, Nauzer Forbes 3, Ali Zakaria 4, Christian Davis 5, Andrew Canakis 6, Emad Qayed 7, Benjamin Bick 8, Swati Pawa 9, William M. Tierney 10, Caroline G. McLeod 1, Jason Taylor 11, Harsh Patel 12, Robin B. Mendelsohn 13, Gokul Bala 14, Ian Sloan 15, Ambreen A. Merchant 16, Zachary L. Smith 17, Morgan A. Sendzischew Shane 18, Olga C. Aroniadis 19…Douglas Drossman 20
doi : 10.1016/j.cgh.2023.11.009
Volume 22, Issue 5, May 2024, Pages 1098-1107.e3
Smoking and Alcohol Consumption and Risk of Incident Diverticulitis in Women
Sarah A. Gunby 1 ∗, Wenjie Ma 2 3 ∗, Miriam J. Levy 1, Edward L. Giovannucci 4, Andrew T. Chan 2 3 4 5 §, Lisa L. Strate 1 §
doi : 10.1016/j.cgh.2023.11.036
Volume 22, Issue 5, May 2024, Pages 1108-1116
Impact of Clinical and Endoscopic Features on the Development of Metachronous Colorectal Advanced Serrated Lesions
Carol Rouphael 1 ∗, Jessica El Halabi 2 ∗, James Bena 3, John McMichael 4, Carol A. Burke 1
doi : 10.1016/j.cgh.2023.07.020
Volume 22, Issue 5, May 2024, Pages 1117-1126.e6
Switching From Intravenous to Subcutaneous Infliximab is Safe and Feasible in Patients With Inflammatory Bowel Disease Suffering From Obesity: A Post Hoc Analysis of the REMSWITCH Study
Anthony Buisson, Maria Nachury, Bruno Pereira, Mathurin Fumery
doi : 10.1016/j.cgh.2023.09.027
Volume 22, Issue 5, May 2024, Pages 1127-1129.e2
Health System–Provided Rideshare Is Safe and Addresses Barriers to Colonoscopy Completion
Rachel B. Issaka, Ari Bell-Brown, Talor Hopkins, Lisa D. Chew, Lisa L. Strate, Bryan J. Weiner
doi : 10.1016/j.cgh.2023.09.030
Volume 22, Issue 5, May 2024, Pages 1130-1132.e1
Artificial Intelligence Chatbot Shows Multiple Inaccuracies When Responding to Questions About Eosinophilic Esophagitis
Corey J. Ketchem, Kristle L. Lynch, Joy W. Chang, Evan S. Dellon
doi : 10.1016/j.cgh.2023.10.004
Volume 22, Issue 5, May 2024, Pages 1133-1135
Limited Impact of a Multifaceted Quality Improvement Intervention on Adherence to Pancreatitis Quality Metrics
Rajesh N. Keswani, Joshua Zimmerman, Barbara Buckley, Dharmesh Patel, Justin Boike, John Pandolfino
doi : 10.1016/j.cgh.2023.10.024
Volume 22, Issue 5, May 2024, Pages 1136-1138.e1
Sphingosine 1-Phosphate Receptor Modulators are Effective in Patients With Moderately to Severely Active Ulcerative Colitis and a Prior Biologic Exposure: A Meta-Analysis of Randomized Controlled Trials
Omar Mahmud, Asad Saulat Fatimi, Muhammad Umar Mahar, Arshia Jahangir, Manzar Abbas, Jeffrey A. Berinstein
doi : 10.1016/j.cgh.2023.10.015
Volume 22, Issue 5, May 2024, Pages 1139-1141.e3
Glucagon-Like Peptide-1 Receptor Agonists: Best Choice for Patients With Cirrhosis and Diabetes?
Yuanyuan Li, Xiaoze Wang
doi : 10.1016/j.cgh.2023.08.012
Volume 22, Issue 5, May 2024, Pages 1142-1143
Reply
Fu-Shun Yen, Teng-Shun Yu, Chih-Cheng Hsu, Chii-Min Hwu
doi : 10.1016/j.cgh.2023.09.017
Volume 22, Issue 5, May 2024, Pages 1143-1144.e1
Letter on “Achalasia is Strongly Associated With Eosinophilic Esophagitis and Other Allergic Disorders�
Yun-Feng Li, Shuo-Yan Gau
doi : 10.1016/j.cgh.2023.08.030
Volume 22, Issue 5, May 2024, Pages 1144-1145
Reply
Stuart J. Spechler, Chanakyaram A. Reddy, Kristina Allen-Brady, Amiko M. Uchida, Kathryn A. Peterson, Alessandrina M. Hoffman, Rhonda F. Souza
doi : 10.1016/j.cgh.2023.09.026
Volume 22, Issue 5, May 2024, Page 1145
Evaluating ChatGPT in Medical Contexts: The Imperative to Guard Against Hallucinations and Partial Accuracies
Mauro Giuffrè, Kisung You, Dennis L. Shung
doi : 10.1016/j.cgh.2023.09.035
Volume 22, Issue 5, May 2024, Pages 1145-1146
Multiple Negative Fecal Immunochemical Tests: Is Testing Really Better?
Alejandra Mijangos-Trejo, Jorge Aquino-Matus, Norberto Chávez-Tapia
doi : 10.1016/j.cgh.2023.10.008
Volume 22, Issue 5, May 2024, Pages 1146-1147
Reply
Molla M. Wassie, Graeme P. Young, Jean M. Winter, Charles Cock, Erin L. Symonds
doi : 10.1016/j.cgh.2023.11.007
Volume 22, Issue 5, May 2024, Pages 1147-1148
